O'Shea JC - Search Results

1

A comparison of clinical outcomes between Canadian and American patients after nonurgent coronary stenting.

Madan M, Labinaz M, Cohen EA, Buller CE, Cantor WJ, Seidelin P, Ducas J, Carere RG, Natarajan MK, Pieper KS, Hafley GE, O'Shea JC, Kitt MM, Califf RM, Tcheng JE; ESPRIT Investigators. Madan M, et al. Among authors: o shea jc. Can J Cardiol. 2004 Nov;20(13):1343-9. Can J Cardiol. 2004. PMID: 15570357 Clinical Trial.

2

Temporal spectrum of ischemic complications with percutaneous coronary intervention: the ESPRIT experience.

Cantor WJ, Tcheng JE, Blankenship JC, O'Shea JC, Pieper KS, Criger DA, Madan M, Ducas J, Sheldon WS, Tannenbaum MA, Smith JE, Kitt MM, Gilchrist IC. Cantor WJ, et al. Among authors: o shea jc. J Invasive Cardiol. 2004 Sep;16(9):475-81. J Invasive Cardiol. 2004. PMID: 15353828 Clinical Trial.

3

Bailout use of platelet glycoprotein IIb-IIIa inhibition during coronary stent implantation: observations from the ESPRIT trial.

Cantor WJ, Madan M, O'Shea JC, Chisholm RJ, Lui HK, Cohen DJ, Feldman RL, Green R, Hellkamp AS, Kitt MM, Tcheng JE. Cantor WJ, et al. Among authors: o shea jc. J Invasive Cardiol. 2005 Jul;17(7):360-4. J Invasive Cardiol. 2005. PMID: 16003020 Clinical Trial.

4

Effect of operator and institutional volume on clinical outcomes after percutaneous coronary interventions performed in Canada and the United States: a brief report from the Enhanced Suppression of the Platelet glycoprotein IIb/IIIa Receptor with Integrilin Therapy (ESPRIT) study.

Madan M, Nikhil J, Hellkamp AS, Pieper KS, Labinaz M, Cohen EA, Buller CE, Cantor WJ, Seidelin P, Ducas J, Carere RG, Natarajan MK, O'Shea JC, Tcheng JE; ESPRIT Investigators. Madan M, et al. Among authors: o shea jc. Can J Cardiol. 2009 Aug;25(8):e269-72. doi: 10.1016/s0828-282x(09)70120-5. Can J Cardiol. 2009. PMID: 19668787 Free PMC article.

5

Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT Trial).

Reddan DN, O'Shea JC, Sarembock IJ, Williams KA, Pieper KS, Santoian E, Owen WF, Kitt MM, Tcheng JE. Reddan DN, et al. Am J Cardiol. 2003 Jan 1;91(1):17-21. doi: 10.1016/s0002-9149(02)02991-0. Am J Cardiol. 2003. PMID: 12505565 Clinical Trial.

6

Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention.

O'Shea JC, Buller CE, Cantor WJ, Chandler AB, Cohen EA, Cohen DJ, Gilchrist IC, Kleiman NS, Labinaz M, Madan M, Hafley GE, Califf RM, Kitt MM, Strony J, Tcheng JE; ESPRIT Investigators. O'Shea JC, et al. JAMA. 2002 Feb 6;287(5):618-21. doi: 10.1001/jama.287.5.618. JAMA. 2002. PMID: 11829701 Clinical Trial.

7

Eptifibatide: a potent inhibitor of the platelet receptor integrin glycoprotein IIb/IIIa.

O'Shea JC, Tcheng JE. O'Shea JC, et al. Expert Opin Pharmacother. 2002 Aug;3(8):1199-210. doi: 10.1517/14656566.3.8.1199. Expert Opin Pharmacother. 2002. PMID: 12150697 Review.

8

Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention?. Lessons from the ESPRIT study.

Fernandes LS, Tcheng JE, O'Shea JC, Weiner B, Lorenz TJ, Pacchiana C, Berdan LG, Maresh KJ, Joseph D, Madan M, Mann T, Kilaru R, Hochman JS, Kleiman NS; ESPRIT investigators. Fernandes LS, et al. J Am Coll Cardiol. 2002 Sep 18;40(6):1085-91. doi: 10.1016/s0735-1097(02)02120-4. J Am Coll Cardiol. 2002. PMID: 12354432 Free article.

9

Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention.

Tcheng JE, Madan M, O'Shea JC, Cohen EA, Buller CE, Lincoff AM, Popma JJ, Teirstein PS, Kitt MM, Lorenz TJ, Greenberg S, Fost N, Califf RM. Tcheng JE, et al. J Interv Cardiol. 2003 Apr;16(2):97-105. doi: 10.1046/j.1540-8183.2003.08020.x. J Interv Cardiol. 2003. PMID: 12768912

10

Optimal duration of eptifibatide infusion in percutaneous coronary intervention (an ESPRIT substudy).

Rebeiz AG, Dery JP, Tsiatis AA, O'shea JC, Johnson BA, Hellkamp AS, Pieper KS, Gilchrist IC, Slater J, Muhlestein JB, Joseph D, Kitt MM, Tcheng JE; ESPRIT substudy. Rebeiz AG, et al. Among authors: o shea jc. Am J Cardiol. 2004 Oct 1;94(7):926-9. doi: 10.1016/j.amjcard.2004.06.030. Am J Cardiol. 2004. PMID: 15464679 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters